Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
What to know about the "wild, wild West" of viral peptide claims - 2Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
- 3Understanding the Rudiments of Tree Administrations
- 4Two Endangered Bengal Tiger Cubs Die Days Apart at Zoo After Contracting Virus
- 54 Coolers for Present day Kitchens
- Israeli president concerned over proposed renaming of park
- Astronomers spot white dwarf star creating a colorful shockwave
- Kidneys from Black donors are more likely to be thrown away − a bioethicist explains why
- Artemis II's moonbound toilet is working again to astronauts' relief after overnight fix
- Manual for 6 famous sorts of cheddar
- Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
- Volkswagen Just Built a Plug-In Tiguan for China That America Doesn’t Get
- Taylor Swift changes 2 song lyrics on 'Reputation' on the night of her Eras tour documentary premiere
- What to know about Jack Dorsey's new Vine revival, DiVine
